Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2021-03-30 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于举行2020年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about holding an online performance explanation meeting for the fiscal year 2020. It invites investors to participate in the event and submit questions in advance. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement about an upcoming investor presentation event focused on discussing the company's 2020 performance. Given the nature of the document as a notification for an investor meeting to explain performance, it fits best under the category 'Investor Presentation' (IP). The document length is short and it is clearly a notice for a meeting rather than the meeting materials or transcript itself.
2021-03-30 Chinese
2020年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the fiscal year ending December 31, 2020, issued by the board of 福安药业（集团）股份有限公司. It discusses the company's internal control systems, evaluation scope, control measures, and defect recognition standards. The content focuses on internal control effectiveness, governance, risk management, and compliance with internal control regulations. It does not contain financial statements or quarterly/yearly financial results but is a detailed report on internal control evaluation. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations, excluding full annual reports. The document length (7025 characters) and detailed content support this classification rather than a brief announcement or a regulatory filing. Therefore, the filing type is AR with high confidence. FY 2020
2021-03-30 Chinese
2020年度募集资金实际存放与使用情况的审核报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report on the actual deposit and use of raised funds for the year 2020 by 福安药业（集团）股份有限公司. It is issued by 永拓会计师事务所, a certified public accounting firm, and includes detailed audit opinions, responsibilities, and verification of the company's compliance with regulatory requirements regarding the management and use of raised funds. The document contains detailed financial data and analysis about the raised funds, their usage, changes in investment projects, and cash management. It is not a full annual report but a standalone audit report focused on the raised funds usage and compliance. The presence of audit opinions and the nature of the content align with the definition of an Audit Report / Information (AR). The document length (8764 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2020
2021-03-30 Chinese
2020年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2020 年度财务决算报告" which translates to "2020 Annual Financial Settlement Report". It contains detailed financial data for the full year 2020, including income statement, balance sheet, cash flow statement, and financial ratios. The report mentions that the financial statements were audited by an accounting firm with an unqualified opinion, indicating it is a full audited financial report. The document length is 5763 characters, which is sufficient to contain substantive financial data rather than just an announcement. The content includes comprehensive financial performance and position data for the full fiscal year, consistent with an Annual Report. There is no indication that this is merely an announcement or a certification letter. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-03-30 Chinese
2020年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2020 年年度报告摘要" which translates to "2020 Annual Report Summary". It contains detailed financial data for the year 2020, including revenue, net profit, earnings per share, and asset totals. It also discusses business operations, accounting policy changes, and company structure changes during the year. The presence of audited financial statements and comprehensive business and financial information indicates this is a summary of the full annual report. The document length is 9905 characters, which is substantial and contains actual financial data, not just an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-03-30 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding multiple reports and proposals related to the 2020 fiscal year, including the 2020 Supervisory Board Work Report, 2020 Financial Final Report, 2020 Audit Report, 2020 Annual Report, Internal Control Evaluation Report, Profit Distribution Plan, and other related matters. The document states that these reports are published simultaneously on the designated disclosure website, indicating this document itself is not the full reports but a summary of resolutions passed by the Supervisory Board to be submitted to the 2020 Annual General Meeting for approval. The document length is about 2994 characters, which is relatively short and mainly serves as an announcement of resolutions and references to the actual reports elsewhere. Therefore, this document fits best as a Regulatory Filing (RNS) because it does not contain the full financial data or detailed reports but announces supervisory board resolutions and references to reports published elsewhere.
2021-03-30 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.